TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
CNXU

Conexeu Sciences Inc.

Healthcare · Biotechnology

2.20$ -3.5% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns Conexeu Sciences Inc. (CNXU)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 53.4% of the shares are freely tradable; institutional investors hold 0.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.02%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 44.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 53.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 31Mio.

Largest Shareholders

Institutions

Institutions CNXU
Name Stake (%) Shares Change (%) Date
UBS Group AG 0.04 12,264 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 0.02 5,871 +0.0 06/30/2026
Citigroup Inc 0.02 5,219 +0.0 06/30/2026
Hollencrest Securities, LLC 0.00 1,000 +0.0 06/30/2026
Royal Bank of Canada 0.00 887 +0.0 06/30/2026
Mercer Global Advisors Inc. 0.00 425 +0.0 06/30/2026
Integrated Wealth Concepts LLC 0.00 400 +0.0 06/30/2026
JONES FINANCIAL COMPANIES LLLP 0.00 100 +0.0 06/30/2026

Funds

Funds CNXU
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 0.30 92,284 +0.0 09/30/2026
Vanguard U.S. Eq Idx £ Acc 0.02 6,726 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings CNXU
Person Role Shares Value As of Type
Purcell Lynn Sebastian Director 6,070,362 13,354,796 $ Sep 4, 2026 indirect
Bogart David Robert Chief Commercial Officer 1,812,500 3,987,500 $ Sep 25, 2026 direct
Sharpe Jeffrey Nathan Director 1,500,000 3,300,000 $ Sep 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 15, 2026 Purcell Lynn Sebastian Director Buy 166,666 3.00 499,998
Sep 25, 2026 Bogart David Robert Chief Commercial Officer Other 750,000 0.001 750
Sep 14, 2026 Sharpe Jeffrey Nathan Director Other 500,000 0.001 500
Sep 4, 2026 Purcell Lynn Sebastian Director Other 217,608 2.30 500,498

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?